Oxycodone Completed Phase 3 Trials for Moderate-to-severe Chronic Noncancer Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02603705Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain